BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 32356894)

  • 21. RNA demethylase ALKBH5 promotes ovarian carcinogenesis in a simulated tumour microenvironment through stimulating NF-κB pathway.
    Jiang Y; Wan Y; Gong M; Zhou S; Qiu J; Cheng W
    J Cell Mol Med; 2020 Jun; 24(11):6137-6148. PubMed ID: 32329191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ALKBH5 Promotes Multiple Myeloma Tumorigenicity through inducing m
    Yu T; Yao L; Yin H; Teng Y; Hong M; Wu Q
    Int J Biol Sci; 2022; 18(6):2235-2248. PubMed ID: 35414790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FTO, m
    Mauer J; Jaffrey SR
    FEBS Lett; 2018 Jun; 592(12):2012-2022. PubMed ID: 29754392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. K235 acetylation couples with PSPC1 to regulate the m
    Zhang XL; Chen XH; Xu B; Chen M; Zhu S; Meng N; Wang JZ; Zhu H; Chen D; Liu JB; Yan GR
    Nat Commun; 2023 Jun; 14(1):3815. PubMed ID: 37369679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oxidative demethylase ALKBH5 repairs DNA alkylation damage and protects against alkylation-induced toxicity.
    Akula D; O'Connor TR; Anindya R
    Biochem Biophys Res Commun; 2021 Jan; 534():114-120. PubMed ID: 33321288
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The m6A demethylase ALKBH5 controls trophoblast invasion at the maternal-fetal interface by regulating the stability of
    Li XC; Jin F; Wang BY; Yin XJ; Hong W; Tian FJ
    Theranostics; 2019; 9(13):3853-3865. PubMed ID: 31281518
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Post-translational modification of RNA m6A demethylase ALKBH5 regulates ROS-induced DNA damage response.
    Yu F; Wei J; Cui X; Yu C; Ni W; Bungert J; Wu L; He C; Qian Z
    Nucleic Acids Res; 2021 Jun; 49(10):5779-5797. PubMed ID: 34048572
    [TBL] [Abstract][Full Text] [Related]  

  • 28. N
    Zhu Z; Qian Q; Zhao X; Ma L; Chen P
    Gene; 2020 Mar; 731():144348. PubMed ID: 31927006
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bone-derived mesenchymal stem cells alleviate compression-induced apoptosis of nucleus pulposus cells by N6 methyladenosine of autophagy.
    Li G; Song Y; Liao Z; Wang K; Luo R; Lu S; Zhao K; Feng X; Liang H; Ma L; Wang B; Ke W; Yin H; Zhan S; Li S; Wu X; Zhang Y; Yang C
    Cell Death Dis; 2020 Feb; 11(2):103. PubMed ID: 32029706
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N(6)-Methyladenosine: a conformational marker that regulates the substrate specificity of human demethylases FTO and ALKBH5.
    Zou S; Toh JD; Wong KH; Gao YG; Hong W; Woon EC
    Sci Rep; 2016 May; 6():25677. PubMed ID: 27156733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RBM33 is a unique m
    Yu F; Zhu AC; Liu S; Gao B; Wang Y; Khudaverdyan N; Yu C; Wu Q; Jiang Y; Song J; Jin L; He C; Qian Z
    Mol Cell; 2023 Jun; 83(12):2003-2019.e6. PubMed ID: 37257451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HPV E7-drived ALKBH5 promotes cervical cancer progression by modulating m6A modification of PAK5.
    Huo FC; Zhu ZM; Du WQ; Pan YJ; Jiang X; Kang MJ; Liu BW; Mou J; Pei DS
    Pharmacol Res; 2023 Sep; 195():106863. PubMed ID: 37480971
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RBM33: A new regulator of N-6-methyladenosine (m
    Zhang P; Abdel-Wahab O
    Mol Cell; 2023 Jun; 83(12):1956-1958. PubMed ID: 37327770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MYC promotes cancer progression by modulating m
    Wu G; Suo C; Yang Y; Shen S; Sun L; Li ST; Zhou Y; Yang D; Wang Y; Cai Y; Wang N; Zhang H; Yang YG; Cao J; Gao P
    EMBO Rep; 2021 Mar; 22(3):e51519. PubMed ID: 33426808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. EGFR promotes ALKBH5 nuclear retention to attenuate N6-methyladenosine and protect against ferroptosis in glioblastoma.
    Lv D; Zhong C; Dixit D; Yang K; Wu Q; Godugu B; Prager BC; Zhao G; Wang X; Xie Q; Bao S; He C; Heiland DH; Rosenfeld MG; Rich JN
    Mol Cell; 2023 Dec; 83(23):4334-4351.e7. PubMed ID: 37979586
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ALKBH5 suppresses malignancy of hepatocellular carcinoma via m
    Chen Y; Zhao Y; Chen J; Peng C; Zhang Y; Tong R; Cheng Q; Yang B; Feng X; Lu Y; Xie H; Zhou L; Wu J; Zheng S
    Mol Cancer; 2020 Aug; 19(1):123. PubMed ID: 32772918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypoxia-inducible factors regulate pluripotency factor expression by ZNF217- and ALKBH5-mediated modulation of RNA methylation in breast cancer cells.
    Zhang C; Zhi WI; Lu H; Samanta D; Chen I; Gabrielson E; Semenza GL
    Oncotarget; 2016 Oct; 7(40):64527-64542. PubMed ID: 27590511
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Demethylase ALKBH5 suppresses invasion of gastric cancer via PKMYT1 m6A modification.
    Hu Y; Gong C; Li Z; Liu J; Chen Y; Huang Y; Luo Q; Wang S; Hou Y; Yang S; Xiao Y
    Mol Cancer; 2022 Feb; 21(1):34. PubMed ID: 35114989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased N6-methyladenosine causes infertility is associated with FTO expression.
    Ding C; Zou Q; Ding J; Ling M; Wang W; Li H; Huang B
    J Cell Physiol; 2018 Sep; 233(9):7055-7066. PubMed ID: 29384212
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ALKBH5 regulates cardiomyocyte proliferation and heart regeneration by demethylating the mRNA of YTHDF1.
    Han Z; Wang X; Xu Z; Cao Y; Gong R; Yu Y; Yu Y; Guo X; Liu S; Yu M; Ma W; Zhao Y; Xu J; Li X; Li S; Xu Y; Song R; Xu B; Yang F; Bamba D; Sukhareva N; Lei H; Gao M; Zhang W; Zagidullin N; Zhang Y; Yang B; Pan Z; Cai B
    Theranostics; 2021; 11(6):3000-3016. PubMed ID: 33456585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.